Basic Information
| LncRNA/CircRNA Name | circ_0081143 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | Cisplatin | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | luciferase reporter assay, Microarray |
| Sample | GC tissues and cell line |
| Expression Pattern | up-regulated |
| Function Description | High throughput microarray assay showed that hsa_circ_0081143 was upregulated in GC tissues, which was further confirmed by qRT-PCR. |
| Pubmed ID | 30733646 |
| Year | 2019 |
| Title | hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway. |
External Links
| Links for circ_0081143 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |